LIXTE BIOTECHNOLOGY HLDGS IN's ticker is LIXT and the CUSIP is 539319202. A total of 16 filers reported holding LIXTE BIOTECHNOLOGY HLDGS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $84,003 | +646076.9% | 101,209 | +292.4% | 0.00% | – |
| Q4 2022 | $13 | -99.9% | 25,794 | 0.0% | 0.00% | – |
| Q3 2022 | $14,000 | -26.3% | 25,794 | 0.0% | 0.00% | – |
| Q2 2022 | $19,000 | -61.2% | 25,794 | -37.0% | 0.00% | – |
| Q1 2022 | $49,000 | +2.1% | 40,973 | +0.8% | 0.00% | – |
| Q4 2021 | $48,000 | -38.5% | 40,658 | +8.4% | 0.00% | – |
| Q3 2021 | $78,000 | – | 37,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANTA MONICA PARTNERS LP | 166,667 | $548,000 | 0.35% |
| Almanack Investment Partners, LLC. | 1,042,105 | $3,429,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 79,735 | $262,000 | 0.05% |
| WELLS FARGO & COMPANY/MN | 16 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,574 | $5,000 | 0.00% |
| MORGAN STANLEY | 21,053 | $69,000 | 0.00% |
| BlackRock Inc. | 303 | $1,000 | 0.00% |
| Citadel Advisors | 23,813 | $79,000 | 0.00% |